Cecilia Rodriguez
Stockholm, Stockholm County, 14178, Sweden
NCT Number: NCT02083263
With the use of Non invasive ventilation the patients with cystic fibrosis will have better lung function (FEV1).
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Stockholm, Stockholm County, 14178, Sweden
3 months intervention between PEP an Bilevel. The patients will follow up under 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 months
3 months
Time frame: up to 3 months
Lung clearance index was calculated as the number of lung volume turnovers (cumulative expired volume divided by the functional residual capacity) required to reduce end-tidal nitrogen concentration to 1/40th of the starting value.
Time frame: 1 month
After physiotherapy will take blood gases (kpa) before chest physiotherapy and perform once a month.
Karolinska University Hospital
Other
Study of Non Invasive Ventilation With High Pressure as Airways Clearance Technique in Adults Patients With Cystic Fibrosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02715921
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Irvine, California, United States
View Trial DetailsNCT04798014
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Indianapolis, Indiana, United States
View Trial DetailsNCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsNCT05453578
Bacterial Disease Carrier, Bacterial Infections
Tucson, Arizona, United States
View Trial Details